Physician profile
Smita Agarwal
NPI 1982675633
$15,143.27
in general payments reported to CMS, 2019-2025
44 companies · $4,693 in 2025
The $4,693 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,023 · 2020: $1,697 · 2021: $1,948 · 2022: $1,592 · 2023: $1,244 · 2024: $1,945 · 2025: $4,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,005 · Consulting Fee: $2,603 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,005.42 |
| Consulting Fee | $2,602.66 |
| Education | $273.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $3,202.00 | 2021-2025 | Opzelura |
| Abbvie INC. | $1,186.01 | 2019-2025 | Rinvoq, Skyrizi |
| Leo Pharma INC. | $1,096.46 | 2019-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $1,094.61 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $1,093.40 | 2019-2025 | Winlevi, Ilumya, Blu-U |
| Janssen Biotech, INC. | $1,026.17 | 2019-2025 | Tremfya |
| Ucb, INC. | $728.17 | 2019-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $676.80 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Mayne Pharma Commercial LLC | $669.04 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $569.71 | 2019-2025 | Siliq, Cabtreo |
| Regeneron Healthcare Solutions, INC. | $445.00 | 2020-2025 | Dupixent |
| Biofrontera INC. | $414.57 | 2019-2021 | |
| Pfizer INC. | $331.72 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $273.29 | 2020-2024 | |
| Lilly USA, LLC | $266.37 | 2019-2025 | Ebglyss, Taltz |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smita Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.